Zheng Quan Shi Bao Wang·2025-06-26 13:02Summary of Key Points Core Viewpoint - Rongchang Biologics (688331) experienced a significant decline in stock price, closing at 60.70 yuan, down 18.36% on June 26, with a trading volume of 1.48 billion yuan and a turnover rate of 14.96% [2][3]. Trading Activity - The stock was listed on the daily trading list due to a price drop of 15% [2]. - The top five trading departments accounted for a total transaction of 607 million yuan, with buying transactions amounting to 235 million yuan and selling transactions totaling 372 million yuan, resulting in a net sell of 137 million yuan [2]. - Among the top buying departments, two were institutional special seats, with buying amounts of 629.26 million yuan and 545.06 million yuan respectively, while the Shanghai-Hong Kong Stock Connect was the third largest buyer with 495.44 million yuan [2][3]. - The selling departments included one institutional special seat with a selling amount of 857.04 million yuan, and the Shanghai-Hong Kong Stock Connect was the fourth largest seller with 635.25 million yuan [2][3]. Net Capital Flow - The stock saw a net outflow of 110 million yuan in main capital throughout the day [3].